Q1 2023 Holdings
Filed 2023-05-15 | 106 holdings | $4.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvalent Inc(NUVL) | COM | 670703107 | $521.6M | 19,991,024 | 11.6% |
| Glaukos Corp | NOTE 2.750% 6/1 | 377322AB8 | $336.2M | $271,752,000 | 7.5% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $176.6M | 1,744,714 | 3.9% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $171.7M | 10,355,099 | 3.8% |
| Natera Inc | NOTE 2.250% 5/0 | 632307AB0 | $164.1M | $101,042,000 | 3.7% |
| Viatris Inc(VTRS) | COM | 92556V106 | $162.9M | 16,935,997 | 3.6% |
| Adapthealth Corp(AHCO) | COMMON STOCK | 00653Q102 | $131.7M | 10,594,914 | 2.9% |
| Tabula Rasa Healthcare Inc | NOTE 1.750% 2/1 | 873379AA9 | $117.3M | $144,516,000 | 2.6% |
| Ionis Pharmaceuticals Inc | NOTE 4/0 | 462222AD2 | $116.9M | $127,800,000 | 2.6% |
| Amedisys Inc(AMED) | COM | 023436108 | $109.1M | 1,483,179 | 2.4% |
| Brookdale SR Living Inc | NOTE 2.000%10/1 | 112463AC8 | $104.8M | $145,955,000 | 2.3% |
| Intercept Pharmaceuticals in | NOTE 3.500% 2/1 | 45845PAC2 | $101.2M | $98,354,000 | 2.3% |
| Accolade Inc | NOTE 0.500% 4/0 | 00437EAB8 | $96.6M | $122,598,000 | 2.2% |
| Apellis Pharmaceuticals Inc | NOTE 3.500% 9/1 | 03753UAB2 | $96.0M | $51,793,000 | 2.1% |
| Insmed Inc | NOTE 1.750% 1/1 | 457669AA7 | $94.4M | $103,200,000 | 2.1% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $80.6M | 5,218,638 | 1.8% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $76.7M | 16,941,357 | 1.7% |
| Pacira Biosciences Inc | NOTE 0.750% 8/0 | 695127AF7 | $75.0M | $81,600,000 | 1.7% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $72.1M | 11,077,927 | 1.6% |
| Centene Corp del(CNC) | COM | 15135B101 | $68.0M | 1,075,000 | 1.5% |
| Silk RD MED Inc | COM | 82710M100 | $67.5M | 1,725,640 | 1.5% |
| Guardant Health Inc | NOTE 11/1 | 40131MAB5 | $59.6M | $89,036,000 | 1.3% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $58.2M | 1,984,333 | 1.3% |
| Nanostring Technologies Inc | NOTE 2.625% 3/0 | 63009RAD1 | $58.0M | $70,204,000 | 1.3% |
| Intercept Pharmaceuticals in | NOTE 3.250% 7/0 | 45845PAA6 | $57.0M | $57,791,000 | 1.3% |
| Owens & Minor Inc New(ACH) | COM | 690732102 | $56.3M | 3,867,455 | 1.3% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $48.8M | 2,032,335 | 1.1% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $48.4M | 16,406,047 | 1.1% |
| Enhabit Inc(EHAB) | COM | 29332G102 | $47.3M | 3,398,746 | 1.1% |
| Hillevax Inc | COM | 43157M102 | $46.8M | 2,833,690 | 1.0% |
| Livongo Health Inc | NOTE 0.875% 6/0 | 539183AA1 | $44.4M | $50,000,000 | 1.0% |
| Merus N V | COM | N5749R100 | $43.8M | 2,380,438 | 1.0% |
| Caremax Inc | COM CL A | 14171W103 | $42.3M | 15,861,090 | 0.9% |
| Springworks Therapeutics Inc | COM | 85205L107 | $40.7M | 1,579,349 | 0.9% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $39.7M | 734,000 | 0.9% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $36.6M | 1,504,578 | 0.8% |
| PTC Therapeutics Inc | NOTE 1.500% 9/1 | 69366JAD3 | $36.3M | $32,000,000 | 0.8% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $33.6M | 2,535,723 | 0.7% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $32.0M | 2,966,345 | 0.7% |
| Evolus Inc(EOLS) | COM | 30052C107 | $30.2M | 3,569,000 | 0.7% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $29.1M | 2,383,000 | 0.6% |
| Health Catalyst Inc | NOTE 2.500% 4/1 | 42225TAB3 | $27.2M | $30,000,000 | 0.6% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $26.9M | 2,402,704 | 0.6% |
| Docgo Inc(DCGO) | COM | 256086109 | $26.5M | 3,059,000 | 0.6% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $26.2M | 3,933,137 | 0.6% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $25.8M | 3,581,000 | 0.6% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $25.0M | 311,949 | 0.6% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $24.4M | 2,059,421 | 0.5% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $23.9M | 1,743,628 | 0.5% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $23.1M | 2,765,000 | 0.5% |